C.O. Ibie
Complexation of novel thiomers and insulin to protect against in vitro enzymatic degradation: towards oral insulin delivery.
Ibie, C.O.; Knott, R.M.; Thompson, C.J.
Authors
R.M. Knott
C.J. Thompson
Abstract
A significant barrier to oral insulin delivery is its enzymatic degradation in the gut. Nano-sized polymer-insulin polyelectrolyte complexes (PECS) have been developed to protect insulin against enzymatic degradation. Poly(allylamine) (Paa) was trimethylated to yield QPaa. Thiolation of Paa and QPaa was achieved by attaching either N-acetylcysteine (NAC), or thiobutylamidine (TBA) ligands (Paa-NAC/QPaa-NAC and Paa-TBA/QPaa-TBA thiomers). PEC formulations were prepared in Tris buffer (pH 7.4) at various polymer:insulin mass ratios (0.2:1-2:1). PECS were characterised by %transmittance of light and photon correlation spectroscopy. Insulin complexation efficiency and enzyme-protective effect of these complexes was determined by HPLC. Complexation with insulin was found to be optimal at mass ratios of 0.4-1:1 for all polymers. PECS in this mass range were positively-charged (20-40 mV), nanoparticles (50-200 nm), with high insulin complexation efficiency (> 90 %). Complexation with TBA polymers appeared to result in disulphide bridge formation between the polymers and insulin. In vitro enzymatic degradation assays of QPaa, Paa-NAC, and QPaa-NAC PECS showed that they all offered some protection against insulin degradation by trypsin and {esc}ga{esc}s-chymotrypsin, but not from pepsin. QPaa-NAC complexes with insulin are the most promising formulation for future work, given their ability to offer protection against intestinal enzymes. This work highlights the importance of optimising polymer structure in the delivery of proteins.
Citation
IBIE, C.O., KNOTT, R.M. and THOMPSON, C.J. 2019. Complexation of novel thiomers and insulin to protect against in vitro enzymatic degradation: towards oral insulin delivery. Drug development and industrial pharmacy [online], 45(1), pages 67-75. Available from: https://doi.org/10.1080/03639045.2018.1517776
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 24, 2018 |
Online Publication Date | Sep 25, 2018 |
Publication Date | Jan 31, 2019 |
Deposit Date | Sep 3, 2018 |
Publicly Available Date | Sep 26, 2019 |
Journal | Drug developement and industrial pharmacy |
Print ISSN | 0363-9045 |
Electronic ISSN | 1520-5762 |
Publisher | Taylor and Francis |
Peer Reviewed | Peer Reviewed |
Volume | 45 |
Issue | 1 |
Pages | 67-75 |
DOI | https://doi.org/10.1080/03639045.2018.1517776 |
Keywords | Thiomers; Insulin; Polymerprotein complexes; Enzymatic degradation; Oral protein delivery |
Public URL | http://hdl.handle.net/10059/3109 |
Contract Date | Sep 3, 2018 |
Files
IBIE 2019 Complexation of novel
(573 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc/4.0/
You might also like
Downloadable Citations
About OpenAIR@RGU
Administrator e-mail: publications@rgu.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search